1211

PARENCHYMAL-SPARING HEPATECTOMY FOR MULTIPLE BILATERAL COLORECTAL LIVER METASTASES: POSITIVE MARGINS ARE NOT ASSOCIATED WITH HIGHER RECURRENCE

Date
May 21, 2024

Background: Surgeons may consider parenchymal-sparing (PSH) or one-stage major hepatectomy (MH) for patients with bilateral colorectal liver metastases (CLM). However, outcomes of these two approaches for patients with advanced bilateral disease are underreported. We sought to evaluate outcomes between PSH and MH for patients with multiple, bilateral CLM.
Methods: A prospective database was queried for patients with 5 or more bilateral CLM who underwent R0/R1-intent initial one-stage hepatectomy (1998-2022). Postoperative follow-up imaging (computed tomography and/or magnetic resonance imaging) was reviewed to identify local recurrence (at the resection margin) and other intrahepatic recurrences (any intrahepatic recurrence without local recurrence). Outcomes were compared between patients who underwent PSH versus MH (≥ 3 Couinaud segments). Median follow-up was 49 months.
Results: Among 206 patients, median (IQR) number of tumors was 7 (5-9) and maximum tumor size was 3 cm (2-4 cm). 90 (44%) patients underwent PSH and 116 (56%) MH, and PSH had smaller tumors (2 vs. 3.5 cm; p=0.001). No differences were observed in number of tumors (median 7 vs. 7, p=0.392), treatment approach, or mutational profiles between the two groups. Patients who underwent PSH had significantly lower rates of post-hepatectomy liver insufficiency (1% vs. 13%, p=0.030). The use of PSH steadily increased during the study period, and more patients with PSH had margin-positive resection (47% vs. 30%; p=0.02; Fig. 1A). Across the study period, 173 (84%) patients recurred. Median local recurrence-free survival (23 months vs. not reached, p=0.184), recurrence-free survival (RFS, 7 vs. 9 months, p=0.585; Fig. 2A), and hepatic-specific disease-free survival (DFS, 8 vs. 14 months, p=0.320; Fig. 2B) were similar, regardless of the surgical approach. When stratified by tumor number, rates of PSH, margin-positive resection and local recurrence were comparable between PSH and MH (all p>0.100; Fig. 1B). Overall survival was similar between PSH and MH (median 59 vs. 47 months, p=0.072).
Conclusions: For patients with multiple bilateral CLM undergoing R0/R1-intent hepatectomy, PSH is safer and is associated with increased rates of microscopically-positive margins compared to MH, but no difference in hepatic-specific DFS, RFS, or local RFS.
<b>Figure 1. </b>A. Rates of PSH, R1 resection, and local recurrence over the study period. B. Rates of R1 resection (p=0.165), local recurrence (p=0.517), and PSH (p=0.498) according to the number of CLM. PSH, Parenchymal-Sparing Hepatectomy.

Figure 1. A. Rates of PSH, R1 resection, and local recurrence over the study period. B. Rates of R1 resection (p=0.165), local recurrence (p=0.517), and PSH (p=0.498) according to the number of CLM. PSH, Parenchymal-Sparing Hepatectomy.

<b>Figure 2. </b>Kaplan-Meier curves for Recurrence-Free Survival (A) and Hepatic-Specific Disease-Free Survival (B) by surgical approach. PSH, Parenchymal-Sparing Hepatectomy; MH, Major Hepatectomy.

Figure 2. Kaplan-Meier curves for Recurrence-Free Survival (A) and Hepatic-Specific Disease-Free Survival (B) by surgical approach. PSH, Parenchymal-Sparing Hepatectomy; MH, Major Hepatectomy.

Speakers

Speaker Image for Yun Shin Chun
The University of Texas MD Anderson Cancer Center
Speaker Image for Jean-Nicolas Vauthey
MD Anderson Cancer Center
Speaker Image for Timothy Newhook
The University of Texas MD Anderson Cancer Center

Tracks

Related Products

Thumbnail for USE OF AIR LEAK TEST TO REDUCE BILE LEAKS AND ORGAN SPACE INFECTIONS: A STEP TOWARDS MORE DRAIN-FREE HEPATECTOMY PATIENTS
USE OF AIR LEAK TEST TO REDUCE BILE LEAKS AND ORGAN SPACE INFECTIONS: A STEP TOWARDS MORE DRAIN-FREE HEPATECTOMY PATIENTS
Introduction: Though still common practice, the indications for surgical drain placement following hepatectomy have been put into question…
Thumbnail for PREDICTORS OF INSUFFICIENT FUTURE LIVER REMNANT HYPERTROPHY AFTER PORTAL VEIN EMBOLIZATION
PREDICTORS OF INSUFFICIENT FUTURE LIVER REMNANT HYPERTROPHY AFTER PORTAL VEIN EMBOLIZATION
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Thumbnail for HEPATECTOMY BEFORE PRIMARY TUMOR RESECTION AS PREFERRED APPROACH FOR SYNCHRONOUS LIVER METASTASES FROM RECTAL CANCER
HEPATECTOMY BEFORE PRIMARY TUMOR RESECTION AS PREFERRED APPROACH FOR SYNCHRONOUS LIVER METASTASES FROM RECTAL CANCER
LUNCH AND TRAINEE JEOPARDY! 12:00 PM - 1:00 PM LEADERSHIP FORUM, NETWORKING SESSION AND ROUNDTABLES 4:00 PM - 5:30 PM KEYNOTE ADDRESS: FUTURE SCENARIO PLANNING TO PREDICT THE FUTURE OF SURGERY 4:00 PM - 4:30 PM
Thumbnail for VARIATIONS IN LIVER VASCULAR ANATOMY AND IMPLICATIONS FOR HEPATECTOMY
VARIATIONS IN LIVER VASCULAR ANATOMY AND IMPLICATIONS FOR HEPATECTOMY
INTRODUCTION: Variations in hepatic arterial and portal venous anatomy have previously been described; however, a comprehensive evaluation of hepatic vascular anatomy that includes other critical elements relevant to hepatectomy is lacking…